Page 91 - GPD-2-4

Gene & Protein in Disease Gene polymorphism and chronic kidney disease

17. Elghoroury EA, Elshamaa MF, Fadel FI, et al., 2018, nephropathy. Am J Physiol Renal Physiol, 294(4): F697–F701.
CCR2 V64I genotyping: Impact on end stage renal disease https://doi.org/10.1152/ajprenal.00016.2008
development, progression and renal transplantation
outcome. JIBPS, 5(4): 5–11. 23. Kulkarni O, Pawar RD, Purschke W, et al., 2007, Spiegelmer
inhibition of CCL2/MCP-1 ameliorates lupus nephritis in
18. Anders HJ, Vielhauer V, Schlöndorff D, 2003, Chemokines MRL-(Fas)lpr mice. J Am Soc Nephrol, 18(8): 2350–2358.
and chemokine receptors are involved in the resolution or
progression of renal disease. Kidney Int, 63(2): 401–415. https://doi.org/10.1681/ASN.2006121348
https://doi.org/10.1046/j.1523-1755.2003.00750.x 24. Boels MGS, Koudijs A, Avramut MC, et al., 2017, Systemic
monocyte chemotactic protein-1 inhibition modifies renal
19. Kashyap S, Warner GM, Hartono SP, et al., 2016, Blockade macrophages and restores glomerular endothelial glycocalyx
of CCR2 reduces macrophage influx and development of and barrier function in diabetic nephropathy. Am J Pathol,
chronic renal damage in murine renovascular hypertension. 187(11): 2430–2440.
Am J Physiol Renal Physiol, 310(5): F372–F384.
https://doi.org/10.1016/j.ajpath.2017.07.020
https://doi.org/10.1152/ajprenal.00131.2015
25. National Kidney Foundation, 2002, K/DOQI clinical
20. Matsunaga N, Ikeda E, Kakimoto K, et al., 2016, Inhibition practice guidelines for chronic kidney disease: Evaluation,
of G0/G1 switch 2 ameliorates renal inflammation in chronic classification, and stratification. Am J Kidney Dis, 39: S1–S266.
kidney disease. eBioMedicine, 13: 262–273.
26. Köttgen A, Gall ECL, Halbritter J, et al., 2022, Genetics in
https://doi.org/10.1016/j.ebiom.2016.10.008 chronic kidney disease: Conclusions from a kidney disease:
21. Eardley KS, Zehnder D, Quinkler M, et al., 2006, The Improving Global Outcomes (KDIGO) controversies
relationship between albuminuria, MCP-1/CCL2, and conference. Kidney Int, 101(6): 1126–1141.
interstitial macrophages in chronic kidney disease. Kidney https://doi.org/10.1016/j.kint.2022.03.019
Int, 69(7): 1189–1197.
27. Dwivedi RS, Herman JG, McCaffrey TA, et al., Beyond
https://doi.org/10.1038/sj.ki.5000212 genetics: Epigenetic code in chronic kidney disease. Kidney
Int, 79(1): 23–32.
22. Tesch GH, 2008, MCP-1/CCL2: A new diagnostic marker
and therapeutic target for progressive renal injury in diabetic https://doi.org/10.1038/ki.2010.335

Volume 2 Issue 4 (2023) 8 https://doi.org/10.36922/gpd.2253